Compare Dr. Reddys with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs WYETH LTD - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB WYETH LTD DR. REDDYS LAB/
WYETH LTD
 
P/E (TTM) x 33.5 27.7 120.9% View Chart
P/BV x 4.7 5.3 88.0% View Chart
Dividend Yield % 0.5 1.3 39.4%  

Financials

 DR. REDDYS LAB   WYETH LTD
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
WYETH LTD
Mar-13
DR. REDDYS LAB/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs2,8751,044 275.3%   
Low Rs1,888818 230.8%   
Sales per share (Unadj.) Rs930.2298.6 311.6%  
Earnings per share (Unadj.) Rs117.457.2 205.1%  
Cash flow per share (Unadj.) Rs185.858.4 318.0%  
Dividends per share (Unadj.) Rs20.0017.00 117.6%  
Dividend yield (eoy) %0.81.8 46.0%  
Book value per share (Unadj.) Rs844.4249.5 338.5%  
Shares outstanding (eoy) m166.0722.72 730.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.63.1 82.1%   
Avg P/E ratio x20.316.3 124.7%  
P/CF ratio (eoy) x12.815.9 80.4%  
Price / Book Value ratio x2.83.7 75.6%  
Dividend payout %17.029.7 57.4%   
Avg Mkt Cap Rs m395,49621,157 1,869.3%   
No. of employees `00022.00.5 4,464.6%   
Total wages/salary Rs m33,562400 8,390.5%   
Avg. sales/employee Rs Th7,032.813,787.4 51.0%   
Avg. wages/employee Rs Th1,527.9813.0 187.9%   
Avg. net profit/employee Rs Th887.72,643.3 33.6%   
INCOME DATA
Net Sales Rs m154,4826,783 2,277.4%  
Other income Rs m3,375353 957.2%   
Total revenues Rs m157,8577,136 2,212.1%   
Gross profit Rs m31,7821,617 1,965.1%  
Depreciation Rs m11,34827 42,661.7%   
Interest Rs m8896 16,163.6%   
Profit before tax Rs m22,9201,938 1,182.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m3,858632 610.2%   
Profit after tax Rs m19,5001,301 1,499.4%  
Gross profit margin %20.623.8 86.3%  
Effective tax rate %16.832.6 51.6%   
Net profit margin %12.619.2 65.8%  
BALANCE SHEET DATA
Current assets Rs m111,1016,984 1,590.8%   
Current liabilities Rs m58,9732,056 2,868.5%   
Net working cap to sales %33.772.6 46.4%  
Current ratio x1.93.4 55.5%  
Inventory Days Days7999 79.9%  
Debtors Days Days9424 393.5%  
Net fixed assets Rs m101,245244 41,442.9%   
Share capital Rs m830227 365.3%   
"Free" reserves Rs m139,4065,441 2,562.2%   
Net worth Rs m140,2365,668 2,474.2%   
Long term debt Rs m22,00025 88,000.0%   
Total assets Rs m224,6567,901 2,843.4%  
Interest coverage x26.8353.3 7.6%   
Debt to equity ratio x0.20 3,556.7%  
Sales to assets ratio x0.70.9 80.1%   
Return on assets %9.116.5 54.9%  
Return on equity %13.922.9 60.6%  
Return on capital %14.934.0 43.9%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m88,67315 583,375.0%   
Fx outflow Rs m19,1042,677 713.6%   
Net fx Rs m69,569-2,662 -2,613.4%   
CASH FLOW
From Operations Rs m28,704923 3,109.2%  
From Investments Rs m-7,727317 -2,438.3%  
From Financial Activity Rs m-21,326-481 4,433.7%  
Net Cashflow Rs m-314759 -41.4%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 5.4 11.3 47.8%  
FIIs % 35.3 7.2 490.3%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 30.4 50.3%  
Shareholders   75,885 21,978 345.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  WOCKHARDT  ABBOTT INDIA  PANACEA BIOTECH  

Compare DR. REDDYS LAB With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 661 Points; Banking and Finance Stocks Witness Huge Selling(Closing)

Indian share markets fell sharply today, led by weak Asian equities as worries of new lockdowns to stem surging coronavirus cases kept investors cautious worldwide.

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

These 3 Recent Events Will Impact the Price of Gold(Fast Profits Daily)

Jul 1, 2020

Recent developments in the bullion market may put some short term pressure on gold prices.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jul 14, 2020 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS